v3.26.3
EARNINGS PER SHARE AND STOCKHOLDERS’ EQUITY
 6 Months Ended
Sep. 30, 2026
EARNING (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY [Abstract]  
EARNINGS PER SHARE AND STOCKHOLDERS’ EQUITY
2. EARNINGS PER SHARE AND STOCKHOLDERS’ EQUITY:
 
Earnings Per Share
 
A reconciliation of the numerator and denominator of basic and diluted earnings per share is shown below (in thousands, except per share amounts):
For the three months endedFor the six months ended
September 30,September 30,
2026202520262025
Basic earnings per share:
Net earnings$18,772 $27,420 $36,287 $35,167 
Basic weighted-average shares outstanding60,979 65,074 60,743 65,261 
Dilutive effect of common stock options and restricted stock units as computed under the treasury stock method1,223 707 1,282 995 
Diluted weighted-average shares outstanding62,202 65,781 62,024 66,256 
Basic earnings per share:
Basic earnings per share:$0.31 $0.42 $0.60 $0.54 
Diluted earnings per share:
Diluted earnings per share:$0.30 $0.42 $0.59 $0.53 
Anti-dilutive equity awards under stock-based award plans excluded from the determination of diluted earnings per share— 248 327 922 
Earnings per share totals may not sum due to rounding.

Stockholders’ Equity

On February 12, 2026, the Company's board of directors approved an amendment to the existing common stock repurchase program, which was initially adopted in 2011. The amendment authorized an additional $200.0 million in share repurchases, increasing the total amount authorized for repurchase under the common stock repurchase program to $1.5 billion. In addition, it extended the common stock repurchase program duration through December 31, 2027.
In accordance with the Merger Agreement, the Company paused repurchases under its common stock repurchase program through the completion of the Merger. During the three and six months ended September 30, 2026, the Company repurchased $0.0 million and $17.6 million under the common stock repurchase program. Through September 30, 2026, the Company had repurchased a total of 49.2 million shares of its common stock for $1.3 billion under the program, leaving remaining capacity of $244.2 million.
 
Accumulated foreign currency translation adjustments accounted for the $5.6 million accumulated other comprehensive income balance at both September 30, 2026 and March 31, 2026.